Sophia was an undergraduate student at Carnegie Mellon University (CMU) majoring in neurobiology and minoring in chemistry. Sophia was interested in exploring the biological mechanisms behind neurodegenerative diseases and conditions. They were a part of the Ncoa7 project investigating the role of Ncoa7 in lysosomal acidification and influencing ischemic stroke outcomes. They helped with immunohistochemistry experiments, perfusion, sectioning, animal colony maintenance, and data analysis. Outside of the lab, Sophia was the vice president of the Carnegie Mellon University Science Olympiad Organization and enjoyed spending time with their pets. Sophia worked as an R&D intern in the Antibody Discovery and Protein Engineering group at Pfizer in Cambridge, MA. After graduation, Sophia planned to complete a PhD in molecular biology or biological chemistry, focusing on drug discovery and development for neurodegenerative diseases.